Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Composite perioperative lung protection strategies in acute type A aortic dissection surgery
ChiCTR2000040797Phase 4Recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ulinastatin and HTK Custodiol in Acute Type A Aortic Dissection (ATAAD) (4 arms), sponsored by Beijing An Zhen Hospital. Primary endpoints: Oxygenation index and Plasma inflammatory factors. Started Nov 2017; status: recruiting.
02
Drugs
ulinastatinHTK Custodiol
03
Conditions
Acute Type A Aortic Dissection (ATAAD)
Beyond the preview
Go deeper on ChiCTR2000040797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040797.